These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 7492626

  • 1. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.
    Broxmeyer HE, Cooper S, Hague N, Benninger L, Sarris A, Cornetta K, Vadhan-Raj S, Hendrie P, Mantel C.
    Ann Hematol; 1995 Nov; 71(5):235-46. PubMed ID: 7492626
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
    Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3448-58. PubMed ID: 7682242
    [Abstract] [Full Text] [Related]

  • 3. Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family.
    Broxmeyer HE, Cooper S, Li ZH, Lu L, Sarris A, Wang MH, Chang MS, Donner DB, Leonard EJ.
    Ann Hematol; 1996 Jul 15; 73(1):1-9. PubMed ID: 8695717
    [Abstract] [Full Text] [Related]

  • 4. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
    Cooper S, Mantel C, Broxmeyer HE.
    Exp Hematol; 1994 Feb 15; 22(2):186-93. PubMed ID: 8299739
    [Abstract] [Full Text] [Related]

  • 5. Interferon-inducible protein 10 and macrophage inflammatory protein-1 alpha inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line.
    Aronica SM, Mantel C, Gonin R, Marshall MS, Sarris A, Cooper S, Hague N, Zhang XF, Broxmeyer HE.
    J Biol Chem; 1995 Sep 15; 270(37):21998-2007. PubMed ID: 7545174
    [Abstract] [Full Text] [Related]

  • 6. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L, Heimfeld S, Broxmeyer HE.
    Blood Cells; 1994 Sep 15; 20(2-3):436-54. PubMed ID: 7538350
    [Abstract] [Full Text] [Related]

  • 7. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
    Broxmeyer HE, Sherry B, Cooper S, Ruscetti FW, Williams DE, Arosio P, Kwon BS, Cerami A.
    J Immunol; 1991 Oct 15; 147(8):2586-94. PubMed ID: 1918979
    [Abstract] [Full Text] [Related]

  • 8. Suppressive effects of TNF-alpha, TGF-beta1, and chemokines on megakaryocytic colony formation in CD34+ cells derived from umbilical cord blood compared with mobilized peripheral blood and bone marrow.
    Lu L, Wang LS, Cooper RJ, Liu HJ, Turner K, Weich N, Broxmeyer HE.
    J Hematother Stem Cell Res; 2000 Apr 15; 9(2):195-204. PubMed ID: 10813532
    [Abstract] [Full Text] [Related]

  • 9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 10. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY.
    J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433
    [Abstract] [Full Text] [Related]

  • 11. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr 15; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 12. Activin A suppresses proliferation of interleukin-3-responsive granulocyte-macrophage colony-forming progenitors and stimulates proliferation and differentiation of interleukin-3-responsive erythroid burst-forming progenitors in the peripheral blood.
    Mizuguchi T, Kosaka M, Saito S.
    Blood; 1993 Jun 01; 81(11):2891-7. PubMed ID: 8499628
    [Abstract] [Full Text] [Related]

  • 13. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.
    Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, Wagner J, Vadhan-Raj S, Benninger L, Rubinstein P.
    Proc Natl Acad Sci U S A; 1992 May 01; 89(9):4109-13. PubMed ID: 1373894
    [Abstract] [Full Text] [Related]

  • 14. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells.
    Broxmeyer HE, Sherry B, Lu L, Cooper S, Oh KO, Tekamp-Olson P, Kwon BS, Cerami A.
    Blood; 1990 Sep 15; 76(6):1110-6. PubMed ID: 2205307
    [Abstract] [Full Text] [Related]

  • 15. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential.
    Carow CE, Hangoc G, Cooper SH, Williams DE, Broxmeyer HE.
    Blood; 1991 Nov 01; 78(9):2216-21. PubMed ID: 1718490
    [Abstract] [Full Text] [Related]

  • 16. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
    Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC.
    Blood Cells; 1987 Nov 01; 13(1-2):31-48. PubMed ID: 3499193
    [Abstract] [Full Text] [Related]

  • 17. Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue.
    Broxmeyer HE, Cooper S, Cacalano G, Hague NL, Bailish E, Moore MW.
    J Exp Med; 1996 Nov 01; 184(5):1825-32. PubMed ID: 8920870
    [Abstract] [Full Text] [Related]

  • 18. Stromal cell-derived factor-1/CXCL12 selectively counteracts inhibitory effects of myelosuppressive chemokines on hematopoietic progenitor cell proliferation in vitro.
    Broxmeyer HE, Cooper S, Hangoc G, Kim CH.
    Stem Cells Dev; 2005 Apr 01; 14(2):199-203. PubMed ID: 15910246
    [Abstract] [Full Text] [Related]

  • 19. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
    Briggs M, Adams JA, Brereton ML, Burgess R, Hyde K, Lenehan H, Yin JA.
    Br J Haematol; 2001 Dec 01; 115(3):563-8. PubMed ID: 11736936
    [Abstract] [Full Text] [Related]

  • 20. Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression.
    Mantel C, Aronica S, Luo Z, Marshall MS, Kim YJ, Cooper S, Hague N, Broxmeyer HE.
    J Immunol; 1995 Mar 01; 154(5):2342-50. PubMed ID: 7532666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.